Biotechnology Products Companies in China

  • ID: 3453668
  • Report
  • Region: China
  • 147 pages
  • AMID Co
1 of 5
China's demand for Bio Industry will continue to grow at 15% by 2027
This study focuses on China’s Biotechnology Products industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study analyzes the industry structure, capacities and output. Major producers' production locations, market shares and profiles are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases.

The author is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. They have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. The report provides hard-to-find market data and analyses. The publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.

Major producers in China are profiled. A selection of these companies can be seen in the 'Companies Mentioned' tab. The full list can be viewed upon purchase of the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5
I. EXECUTIVE SUMMARY
Report Scope and Methodology
Executive Summary

II. BIO INDUSTRY ASSESSMENTS
Bio Industry Structure
Market Size
Market Growth Drivers
Bio Industry Capacity
Major Producer Facility Locations, Output and Capacity
Market Share of Key Producers
Market Distribution and Marketing Strategies
Overview
Market Distribution
Marketing Strategies
Product Patent
Overview
History of China Bio-product Patent Application
Analysis of China Bio-product Patent Application Situation
Related Laws and Regulations about Bio-product Patent Application in China
Potential Market Entrance
Overview
Potential Market Entrance
Analysis of China Pharmaceutical Market Entrance Situation

III. BIO PRODUCT PRODUCER DIRECTORY
Bio Product Producer Profiles

LIST OF TABLES

I. INTRODUCTION
Economic Outlook Summary

II. BIO INDUSTRY ASSESSMENTS
Bio Products Industry Capacity and Output in China
Diagnosis Production and Demand
Biopharmaceuticals Production and Demand
Biomedical Materials Production and Demand
Bio Products Industry Demand in China
China’s Bio Industry Capacity by Classification
Major Bio Products Producers’ Output, Capacity and Location
Major Diagnosis Producers’ Output, Capacity and Location
Major Biopharmaceuticals Producers’ Output, Capacity and Location
Major Biomedical Materials Producers’ Output, Capacity and Location
Market Share of Diagnosis Key Producers
Market Share of Biopharmaceuticals Key Producers
Market Share of Biomedical Materials Key Producers
China’s Major Bio Products Distributors and Their Locations

LIST OF CHARTS

I. INTRODUCTION
China’s Bio Products Capacity, Output, Demand

II. BIO INDUSTRY ASSESSMENTS
Bio Products Industry Capacity and Output in China
China’s Diagnosis Consumption by Products
China’s Biopharmaceuticals Consumption by Products
China’s Biomedical Materials Consumption by Products
Bio Products Industry Demand in China
Diagnosis Demand by Classification
Biopharmaceuticals Demand by Classification
Biomedical Materials Demand by Classification
Bio Capacity by Classification
China's Diagnosis Capacity
China's Biopharmaceuticals Capacity
China's Biomedical Materials Capacity
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5


Focus on China’s Healthcare for 1.3 Billion People

In the two past decades, the healthcare industry has been growing at a fast pace. It is a tremendous challenge to provide healthcare for 1.3 billion people. The dramatic expansions of the healthcare system, drug manufacturing, and health insurance have transformed China’s society and economy. Life expectancy reached 76.8 for women and 72.5 for men now comparing to 69.9 for women and 66.9 for men in 1990. Demographic transition from high mortality to low mortality has helped increase life expectancy. Primary diseases have also shifted from infectious to chronic. Cancer, heart diseases and cerebrovascular diseases are now top killers. Spending on healthcare counts for over 5% of GDP now and continue to increase in the next decade.

Healthcare reform has been one of the key topics on the government agenda in China. Due to the rise in the cost of healthcare, more than 10% of the income is spent on healthcare, which is greater than that spent on education and transportation. The rise in the cost in healthcare would definitely have an outcome of the high cost of the drugs.

There are approximately 4,500 pharmaceutical companies in China, the majority of which are small players with limited local market reach. Rapid consolidation between medium and large players in the sector is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to better control the pricing of drugs.

China is one of the world’s major producers of pharmaceuticals. Far outpacing other economies in the world, China is the world’s fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expanding market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of Chinese medicine, low value-added bulk pharmaceuticals or generic drugs.

Biotechnology is a rapidly growing sector in China. Both production and demand have witnessed significant surges in recent years. China will continue to remain a large importer for biotechnology pharmaceuticals to meet the growing domestic demand. Major imports include biotechnology vaccines, CSF, r-EPO, recombinant human insulin, recombinant human growth hormones, recombinant interferon, and other biotechnology pharmaceuticals.

The health care insurance industry of China includes two main parts such as the social healthcare insurance controlled by the government and commercial healthcare insurance provided by private companies. At present, the social healthcare insurance is under reforms to control the increasing healthcare costs. The development of commercial healthcare insurance in China is not inadequate. But the commercial healthcare insurance market has a great growth potential. Today, China has the largest healthcare market in the world. The Chinese healthcare industry is one of the fastest-growing sectors in China, growing at double digit rate each year. Tremendous fast-growing markets for imports and business opportunities for companies around the world.
Note: Product cover images may vary from those shown
5 of 5
Shanghai Roth Pharmaceutic Co., Ltd
Beijing Tri-Prime Genetic Engineering Co., Ltd.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll